VHL Polyclonal antibody

VHL Polyclonal Antibody for IF, IHC,ELISA

Host / Isotype

Rabbit / IgG


human and More (1)





Cat no : 16538-1-AP


HRCA1, Protein G7, pVHL, RCA1, VHL, VHL1, Von Hippe-Lindau

Tested Applications

Positive IHC detected inhuman liver cancer tissue, human kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inHepG2 cells

Recommended dilution

Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)IF : 1:10-1:100
Sample-dependent, check data in validation data gallery

Product Information

16538-1-AP targets VHL in IHC, IF applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen VHL fusion protein Ag9843
Full Name von Hippel-Lindau tumor suppressor
Calculated molecular weight 172 aa, 20 kDa
GenBank accession numberBC058831
Gene symbol VHL
Gene ID (NCBI) 7428
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

VHL (von Hippel-Lindau tumor suppressor) gene was identified as the tumor suppressor gene whose germ line mutations are associated with the inherited von Hippel-Lindau cancer syndrome (PMID: 8603073, 10722748). VHL patients develop a wide variety of tumors including retinal angioma, central nervous system hemangioblastoma, pheochromocytoma, and renal clear cell carcinoma (PMID: 10722748). VHL localizes predominantly to the cytoplasmic compartment but engages in a dynamic nuclear-cytoplasmic shuttle (PMID: 8700833, 9891082, 12101228). VHL has 3 isoforms with the molecular mass of 24, 20 and 18 kDa.


Product Specific Protocols
IHC protocol for VHL antibody 16538-1-APDownload protocol
IF protocol for VHL antibody 16538-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Front Mol Biosci

Network-Based Expression Analyses and Experimental Verifications Reveal the Involvement of STUB1 in Acute Kidney Injury.

Authors - Yanting Shi

Front Oncol

Risk Scores Based on Six Survival-Related RNAs in a Competing Endogenous Network Composed of Differentially Expressed RNAs Between Clear Cell Renal Cell Carcinoma Patients Carrying Wild-Type or Mutant Von Hippel-Lindau Serve Well to Predict Malignancy and Prognosis.

Authors - Rui Zhu


The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.

Authors - Fabao Liu


The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


Jingwen (Verified Customer) (01-27-2020)

This antibody worked very well on the cancer samples by performing western blot and immunofluorescence.

  • Applications: Western Blot,Immunofluorescence,
  • Primary Antibody Dilution: 1:1000 for WB, 1:100 for IF
  • Cell Tissue Type: Cancer tissue

Jie (Verified Customer) (01-27-2020)

achieved positive staining in liver cancer cells

  • Applications: Western Blot,
  • Primary Antibody Dilution: 1:200

Lunfeng (Verified Customer) (01-27-2020)


  • Applications: Immunofluorescence,